FOLFIRINOX vs gemcitabine nab-paclitaxel: A real-world efficacy and safety analysis - a single-centre experience

被引:0
|
作者
Khan, A. M. [1 ]
Noor, S. [2 ]
Ahmed, R. [3 ]
Takreem, S. [2 ]
Shahnoor, S. S. [2 ]
Muddu, V. K. [2 ,4 ]
Bonda, A. [5 ]
Siripurapu, I. [5 ]
Krishnaiah, S. [6 ]
Rao, G. [7 ]
Reddy, N. [8 ]
机构
[1] Asian Inst Gastroenterol, Dept Med Oncol, Hyderabad, India
[2] Anwarul Uloom Coll Pharm, Pharm Practice, Hyderabad, India
[3] Anwarul Uloom Coll Pharm, Pharm, Hyderabad, India
[4] AIG Hosp Hyderabad, Med Oncol, Hyderabad, India
[5] AIG Hosp, Dept Med Oncol, Hyderabad, India
[6] Asian Inst Gastroenterol, Biostat, Hyderabad, India
[7] Asian Inst Gastroenterol, Surg Gastroenterol, Hyderabad, India
[8] Asian Inst Gastroenterol, Med Gastroenterol, Hyderabad, India
关键词
D O I
10.1016/j.annonc.2024.05.517
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
376P
引用
收藏
页码:S152 / S152
页数:1
相关论文
共 50 条
  • [31] A real-world single-centre analysis of the safety and efficacy of cladribine tablets for relapsing multiple sclerosis
    Aerts, S.
    Khan, H.
    Severijns, D.
    Popescu, V.
    Peeters, L. M.
    Van Wijmeersch, B.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 892 - 892
  • [32] Use of nab-paclitaxel and gemcitabine in pancreatic cancer without granulocyte colony-stimulating factor: A multicenter real-world experience
    Chen, Angela
    Ha, Vincent H.
    Ghosh, Sunita
    Chambers, Carole R.
    Sawyer, Michael B.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (07) : 1594 - 1602
  • [33] Comparisons of Outcomes of Real-World Patients With Advanced Pancreatic Cancer Treated With FOLFIRINOX Versus Gemcitabine and Nab-Paclitaxel A Population-Based Cohort Study
    Papneja, Neha
    Zaidi, Adnan
    Chalchal, Haji
    Moser, Michael
    Tan, Kiat
    Olson, Colleen
    Haider, Kamal
    Shaw, John
    Ahmed, Shahid
    PANCREAS, 2019, 48 (07) : 920 - 926
  • [34] Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: A single-centre real-world experience
    Abawi, M.
    Nijhoff, F.
    Stella, P. R.
    Voskuil, M.
    Benedetto, D.
    Doevendans, P. A.
    Agostoni, P.
    NETHERLANDS HEART JOURNAL, 2016, 24 (09) : 544 - 551
  • [35] Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: A single-centre real-world experience
    M. Abawi
    F. Nijhoff
    P.R. Stella
    M. Voskuil
    D. Benedetto
    P.A. Doevendans
    P. Agostoni
    Netherlands Heart Journal, 2016, 24 : 544 - 551
  • [36] Real-world efficacy and safety of naltrexone-bupropion therapy in Chinese patients with obesity: A single-centre experience
    Lui, David Tak Wai
    Tsoi, Kimberly Hang
    Fong, Carol Ho Yi
    Jiang, Nancy Su
    Chow, Wing Sun
    Yuen, Michele Mae Ann
    ENDOCRINE, 2025, 87 (02) : 522 - 529
  • [37] FOLFIRINOX versus gemcitabine nab-paclitaxel for advanced pancreatic cancer: KU Cancer Center experience.
    Kasi, Anup
    Middinti, Akshay
    Cao, An
    Vekaria, Pratikkumar
    Patel, Devangi
    Subramaniam, Dipti
    Chen, Guoqing J.
    Saeed, Anwaar Mohammed
    Paluri, Ravi Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [38] ANALYSIS OF US REAL WORLD EVIDENCE DATA TO ASSESS AND COMPARE THE EFFECTIVENESS OF TWO CHEMOTHERAPY REGIMENS: FOLFIRINOX VS GEMCITABINE/NAB-PACLITAXEL FOR FIRST LINE METASTATIC PANCREATIC CANCER
    Bochenska, K.
    Galusza, M.
    Hodge, J. P.
    Raupp, M. D.
    Zeng, S.
    VALUE IN HEALTH, 2023, 26 (06) : S364 - S364
  • [39] Lipid lowering with inclisiran: a real-world single-centre experience
    Padam, Pritpal
    Barton, Lucy
    Wilson, Stewart
    David, Alessia
    Walji, Shahenaz
    de Lorenzo, Ferruccio
    Ray, Kausik K.
    Jones, Ben
    Cegla, Jaimini
    OPEN HEART, 2022, 9 (02):
  • [40] Sacubitril-Valsartan: real-world single-centre experience
    Climent, Herminio Morillas
    Lopez, Alvaro Vicedo
    Moya, Julia Seller
    Torres, Edgard Alania
    Jornet, Emilio Galcera
    Rodriguez, Ainhoa Larumbe
    Piles, Carlos Nunez
    Munoz, Alfonso Valle
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 257 - 257